Previous 10 | Next 10 |
home / stock / ipatf / ipatf news
IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic Test Canada NewsWire VICTORIA, BC, Oct. 8, 2020 Also signs Definitive Commercial Agreement with University of Victoria VICTORIA, BC , Oct. 8...
IPA's CEO Dr. Jennifer Bath to Appear Live Wednesday on BNN Television Canada NewsWire VICTORIA, BC, Oct. 6, 2020 VICTORIA, BC , Oct. 6, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in fu...
ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends Canada NewsWire VICTORIA, BC, Oct. 05, 2020 VICTORIA, B...
ImmunoPrecise Antibodies (IPATF): FQ1 net loss of $549k.Revenue of $3.76M (+38.2% Y/Y)Press Release For further details see: ImmunoPrecise Antibodies reports FQ1 results
ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021 PR Newswire VICTORIA, BC, Sept. 29, 2020 VICTORIA, BC, Sept. 29, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA"...
IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg Television Canada NewsWire VICTORIA, BC, Sept. 28, 2020 VICTORIA, BC , Sept. 28, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a lead...
ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor Day Canada NewsWire VICTORIA, BC, Sept. 28, 2020 VICTORIA, BC , Sept. 28, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a l...
ImmunoPrecise Antibodies (IPATF) and LiteVax have initiated preclinical vaccine trials against SARS-CoV-2. Vaccine design was based on sets of data obtained during the analysis of IPA's SARS-CoV-2 therapeutic programs, and based on this, the company has designed SARS-CoV-2 spike protein ...
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials PR Newswire VICTORIA, BC, Sept. 25, 2020 VICTORIA, BC , Sept. 25, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-s...
IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™ PR Newswire VICTORIA, BC, Sept. 22, 2020 VICTORIA, BC , Sept. 22, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE...
News, Short Squeeze, Breakout and More Instantly...
ImmunoPrecise Antibodies Ltd. Company Name:
IPATF Stock Symbol:
OTCMKTS Market:
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange Canada NewsWire VICTORIA, BC , Dec. 23, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (Nasdaq Global Markets: IPA), a leader in full-service, therapeu...
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year Canada NewsWire Record Quarterly Revenue of $4,754,545 and Adjusted EBITDA of $795,159 Announced Strategic Partnership ...
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate VICTORIA, BC , Dec. 14, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. ("IPA") (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody discovery and development and LiteVax...